Medtronic Expects FDA Orthopedics Panel Review For InFuse Bone Graft

Medtronic's Sofamor Danek division is anticipating that FDA's Orthopedics and Rehabilitation Devices Advisory Panel will review the firm's PMA submission for the use of InFuse bone graft system in spinal fusion procedures, company officials said